RSV (Respiratory Syncytial Virus) | CDC
www.cdc.gov › rsvNov 7, 2023 · Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious. Infants and older adults are more likely to develop severe RSV and need hospitalization. If you are age 60 or older, a vaccine is available to protect you ...
RS-virus - Sairaana
www.sairaana.com › sairaudet › rs-virusPienillä lapsilla ja vanhuksilla RSV voi aiheuttaa vakavan alempien hengitysteiden tulehduksen, keuhkokuumeen tai ilmatiehyiden tulehduksen. Hengitystievaikeuksissa on otettava heti yhteyttä lääkäriin. Monet eri virukset voivat aiheuttaa flunssan. Noin 25 % lasten flunssista johtuu RS-viruksesta (RSV).
RSV Vaccine Information Statement | CDC
www.cdc.gov › vaccines › hcpRSV is a common respiratory virus that usually causes mild, cold-like symptoms. RSV can cause illness in people of all ages but may be especially serious for infants and older adults. Infants up to 12 months of age (especially those 6 months and younger) and children who were born prematurely, or who have chronic lung or heart disease or a ...
Frequently Asked Questions About RSV Vaccine for Adults | CDC
www.cdc.gov › vaccines › vpdAug 30, 2023 · Two Respiratory Syncytial Virus (RSV) vaccines are approved for people ages 60 years and older. CDC recommends that adults ages 60 years and older may receive RSV vaccination, using shared clinical decision-making (SCDM). This means that health care providers should talk to these individuals about whether RSV vaccination is appropriate for them.